Simplicity Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History

Simplicity Solutions’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$293K	Buy	3,036 +65	+2%	+$5.75K	0.01%	848
2023 Q3	$263K	Buy	2,971 +229	+8%	+$20.4K	0.01%	810
2023 Q2	$238K	Buy	2,742 +82	+3%	+$7.72K	0.01%	913
2023 Q1	$259K	Buy	+2,660	New	+$276K	0.01%	912
2018 Q3	–	Sell	-2,949	Closed	-$278K	–	560
2018 Q2	$278K	Buy	+2,949	New	+$258K	0.02%	385

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Simplicity Solutions's BMRN Position: Q4 2023 in Review

Simplicity Solutions increased its BioMarin Pharmaceuticals (BMRN) stake by 2.2% in Q4 2023, buying an estimated $5.75K and bringing the position to 3,036 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #848.

Simplicity Solutions first reported a position in BMRN in Q2 2018 and has held it in 5 quarters since. 547 funds tracked by Wall St. Rank hold BMRN as of Q4 2023.

Simplicity Solutions held 3,036 shares of BioMarin Pharmaceuticals worth $293K as of Q4 2023.
Simplicity Solutions bought 65 BioMarin Pharmaceuticals shares in Q4 2023, an estimated $5.75K.
BioMarin Pharmaceuticals made up 0.01% of Simplicity Solutions's portfolio in Q4 2023, its #848 holding.
Simplicity Solutions first reported a position in BioMarin Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
547 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.